Once a hydrocephalus diagnosis is confirmed, it’s time to proceed with a plan for treatment. Shunt system, endoscopic third ventriculostomy (ETV), endoscopic third ventriculostomy with choroid plexus cauterization (ETV/CPC), how does a neurosurgeon decide which treatment option a patient is best suited for? What are each procedure’s benefits and possible risks? In our next webinar, Hydrocephalus Treatment Part I: Past, Present, Future of Endoscopic Third Ventriculostomy (ETV) and Endoscopic Third Ventriculostomy with Choroid Plexus Cauterization (ETV/CPC), Dr. Jay Riva-Cambrin will present the first section of this two part webinar. Dr. Riva-Cambrin will provide a general overview of the history of ETV and ETV/CPC as well as discuss the procedures’ criteria for patient selection, and the procedures’ benefits and possible risks. Both ETV and ETV/CPC are promising alternative treatments to shunting which are being explored to treat hydrocephalus. Tune in on Wednesday, March 4, 2015 at 7:00 PM ET.
Wednesday, March 4, 2015
7:00 PM – 8:30 PM ET.
This webinar is ideal for anyone who wants to learn more about the latest on hydrocephalus treatment, including ETV and ETV/CPC.
Jay Riva-Cambrin, MD, BSc, FRCSC, MSc
Max Noorda Endowed Chair, Associate Professor of Neurosurgery, Pediatric Neurosurgery Fellowship Director
Department of Neurosurgery, Division of Pediatric Neurosurgery, University of Utah, Primary Children’s Medical Center, Salt Lake City, Utah
Dr. Riva-Cambrin began his medical studies at the University of Alberta, Canada. After graduating from medical school in June 1998, he completed his residency at the University of Toronto, Canada. He obtained a Masters of Science in Clinical Epidemiology from the University of Toronto under the direction of Dr. James Drake. Dr. Riva-Cambrin completed a postgraduate fellowship in pediatric neurological surgery at The Hospital for Sick Children, University of Toronto in Pediatric Neurosurgery.
Dr. Riva-Cambrin’s clinical interests in Pediatric Neurosurgery include the treatment of hydrocephalus and clinical trials. He is a member of The Hydrocephalus Clinical Research Network (HCRN). He developed a model which predicts hydrocephalus in pediatric tumor patients. Dr. Riva-Cambrin performs over 250 neurosurgeries per year with 100 surgeries being hydrocephalus surgeries. Dr. Riva-Cambrin joined the faculty of the University of Utah and the Primary Children’s Medical Center in 2006 and is an Associate Professor in the Department of Neurosurgery as well as the Program Director for the Pediatric Neurosurgery Fellowship Program. Dr. Riva-Cambrin is one of the Hydrocephalus Association MYIs’ research grant recipients.
We are pleased to offer educational webinars to help you stay informed and current on the latest news surrounding hydrocephalus. Our webinars are free to the public.
For more information on our Support and Education Webinar Series please click here.
Please contact the Hydrocephalus Association by telephone (888) 598-3789 or via e-mail at Jennifer@hydroassoc.org.
This Webinar Series is made possible through the generosity of our industry partners The Batterman Foundation, Medtronic, Aesculap and Sophysa who we thank for supporting this important program!